Tue Micheelsen is an accomplished commercial executive with over 20 years of experience in the biotech industry. He holds an M.Sc. in economics from Copenhagen Business School and concluded leadership and board education programs from Harvard Business School and INSEAD. Mr. Micheelsen joined Novozymes in 2003. In his various executive roles, he has been instrumental in advancing the company’s mission to better the world with biology. Several significant internation assignments mark his leadership experience; He led the company’s Middle East and Africa business out of Vienna and he led Region Asia stationed in Kuala Lumpur, Malaysia. In the newly formed company Novonesis, the world largest bio-solutions company, he is heading up Region North America stationed in North Carolina, USA. Tue Micheelsen joined the Board of NN Pharmatech in 2020.

Lunch and learn at AstraZeneca
Enhance efficiency and safety in upstream biomanufacturing processes On Tuesday, May 20, between 11 AM and 1:30 PM, all employees at AstraZeneca Gaithersburg are invited